High-volume hemofiltration in sepsis and SIRS: Current concepts and future prospects

Blood Purification

Volumn 28, Issue 1, 2009, Pages 1-11

  Honore, Patrick M ^a,e   Joannes Boyau, Olivier ^c   Boer, Willem ^d   Collin, Vincent ^b  

^a Sainte Pierre University Hospital   (Belgium)

^b Clinique Europe St Michel   (Belgium)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d Sittard Geleen Heerlen   (Netherlands)

^e Clinique Saint Pierre of Ottignies   (Belgium)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Dialysis; Hemofiltration; High volume hemofiltration; Sepsis; Systemic inflammation response syndrome

Indexed keywords

ACUTE KIDNEY FAILURE; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; HEMODIALYSIS; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; ULTRAFILTRATION;

ANIMALS; HEMOFILTRATION; HUMANS; SEPSIS;

EID: 62949184906     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210031     Document Type: Review

References (86)

1. Vincent JL, Atalan HK:Epidemiology of severe sepsis in the intensive care unit. Br J Hosp Med 2008; 69:442-443.
2. Damas P, Canivet JL, de Groote D, et al:Sepsis and serum cytokines concentrations. Crit Care Med 1997; 25:405-412.
3. Casey LC, Balk RA, Bone RC:Plasma cyto-kine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778.
4. Honoré PM, Joannes-Boyau O, Kotulak T, et al:Report of the working party on high volume hemofiltration including definitions and classification. Proc 2nd Czech Conference on Critical Care Nephrology, Pardubice, Czech Republic, 2007.
5. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al:Effects of different doses in continuous veno-venous haemofil-tration on outcomes of acute renal failure:a prospective randomised trial. Lancet 2000; 356:26-30.
6. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bellomo R:Interpreting the mechanism of continuous renal replacement therapy in sepsis:the peak concentration hy-pot hesis. Ar tif Organs 2003; 27:792-801.
7. Brendolan A, D'Intini V, Ricci Z, et al:Pulse high volume hemofiltration. Int J Artif Organs 2004; 27:398-403.
8. Ronco C, Ricci Z, Bellomo R:Importance of increased ultrafiltration volume and impact on mortality:sepsis and cytokine story and the role for CV VH. EDTR A ERCA J 2002; 2:13-18.
9. Honoré PM, Joannes-Boyau O:High volume hemofiltration (HVHF) in sepsis:a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004; 27:1077-1082.
10. Honoré PM, Matson JR:Extracorporeal removal for sepsis:acting at the tissue level. The beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004; 32:896-897.
11. Honoré PM, Boer W, Joannes-Boyau O, Gressens B:High volume haemofiltration and hybrid techniques in sepsis:new insights into the rationale. Neth J Crit Care 2007; 11:239-242.
12. Honoré PM, Joannes-Boyau O, Gressens B:Blood and plasma treatments:the rationale of high-volume hemofiltration. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 387-395.
13. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ:Continuous veno-ve-nous hemofiltration improves hemodynamic in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 2002; 15:150-157.
14. Di Carlo JV, Alexander SR:Hemofiltration for cytokine-driven illness:the mediator delivery hypothesis. Int J Artif Organs 2005; 28:777-786.
15. Olszewski WL:The lymphatic system in body homeostasis:physiological conditions. Lymph Fat Res Biol 2003; 1:11-21.
16. Onarherim H, Missavage E, Gunther RA, Kramer GC, Reed RK, Laurent TC:Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res 1991; 50:259-265.
17. Wasserman K, Mayerson HS:Dynamics of lymph and plasma protein and exchange Cardiologia 1952; 21:296-307.
18. Cho KC, Himmelfarb J, Paganini E, et al:Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 2006; 17:3132-3138.
19. Schiffl H, Lang SM, Fisher R:Daily hemodi-alysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-310.
20. Ronco C,Bellomo R, Homel P, et al:Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure:a prospective randomised trial. EDTNA ERCA J 2002; (suppl 2):7-12.
21. Saudan P, Niederberger M, De Seigneux S, et al:Adding a dialysis dose to continuous he-mofiltration increases survival in patients with acute renal fai lure. Kidney Int 2006; 70:1312-1317.
22. Bouman CS, Oudemans-Van-Straaten HM, Tijssen JG, Zandstra DF, Kosecioglu J:Effects of early high-volume continuous veno-venous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure:a prospective, randomized trial. Crit Care Med 2002; 30:2205-2211.
23. Tolwani AJ, Campbell RC, Stofan BS, et al:Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008; 19:1233-1238.
24. Honoré PM, Jamez J, Wauthier M, et al:Prospective evaluation of short term high volume isovolemic haemofiltration on the hae-modynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28:3581-3587.
25. Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J:Extracorporeal blood treatment (EBT) methods in SIRS/sepsis. ADQI III Conference. Int J Artif Organs 2005; 28:450-458.
26. Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J:Extracorporeal blood treatment (EBT) methods in SIRS/sepsis. Consensus statement. ADQI III Conference. Electronic Supplement Material, 2005. www. adqi.net.
27. Bouman CS, Oudemans HM:Guidelines for timing, dose, and mode of continuous replacement therapy for acute renal failure in the critically ill. Neth J Crit Care 2006; 10:561-568.
28. Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB:Hemofiltration in sepsis and systemic inflammatory response syndrome:the role of dosing and timing. J Crit Care 2007; 22:1-12.
29. Lee PA, Weger G, Pryor RW, Matson JR:Effects of filter pore size on efficacy of continuous arterio-venous haemofiltration therapy for staphylococcus aureus-induced septicaemia in immature swine. Crit Care Med 1998; 26:730-737.
30. Lee WC, Uchino S, Fealy N, et al:Super high flux hemodialysis at high dialysate flows:an ex vivo assessment. Int J Artif Organs 2004; 27:24-28.
31. Honoré PM, Matson JR:Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care 2002; 6:394-396.
32. Rogiers P:Improved short-term outcomes with early use of isovolemic hemofiltration in patients with septic shock. Nat Clin Pract Nephrol 2006; 2:478-479.
33. Honoré PM, Zydney AL, Matson JR:High volume and high permeability haemofiltra-tion in sepsis:the evidences and the key issues. Care Crit Ill 2003; 3:69-76.
34. Matson JR, Zydney RL, Honoré PM:Blood filtration:new opportunities and the implications on system biology. Crit Care Resusc 2004; 6:209-218.
35. Klingel R, Ahrenholz P, Schwarting A, Ro-ckel A:Enhanced functional performance characteristics of a new polysulfone membrane for high-flux hemodialysis. Blood Pu-rif 2002; 20:325-333.
36. House AA, Ronco C:Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury. Blood Purif 2008; 26:30-35.
37. Morgera S, Haase M, Kuss T, et al:Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006; 34:2099-2104.
38. Uchino S, Bellomo R, Goldsmith D, et al:Super high flux hemofiltration:a new technique for cytokine removal. Intensive Care Med 2002; 28:651-655.
39. Bellomo R, Tetta C, Ronco C:Coupled plasma filtration adsorption. Intensive Care Med 2003; 29:1222-1228.
40. Valbonesi M, Carlier P, Icone A, Accorsi P, Borberg H, Schreiner T, et al:Cascade filtration:a new filter for secondary filtration:a multicentric study. Int J Artif Organs 2004; 27:513-515.
41. Joannes-Boyau O, Honoré PM, Boer W:He-mofiltration:the case for removal of sepsis mediators from where they do harm. Crit Care Med 2006; 34:2244-2246.
42. Honoré PM, Joannes-Boyau O, Meurson L, Boer W, Piette V, Galloy AC, et al:The big bang of haemofiltration:the beginning of a new era in the third millennium for extra-corporeal blood purification. Int J Artif Organs 2006; 29:649-659.
43. Honoré PM, Joannes-Boyau O:'The French Hemodiafe Trial':not either a decisive nor a definitive study regarding controversy for renal replacement therapy in the ICU field. Int J Artif Organs 2006; 29:1190-1192.
44. ANZICS Clinical Trials Group:Last accessed in September 2008. Augmented vs. normal renal replacement therapy in severe acute renal failure (renal study). ClinicalTri-als.gov/ct2/show/NCT00221013.
45. Honoré PM, Joannes-Boyau O:The IVOIRE Study:impact of high volume haemofiltra-tion in early septic shock with acute renal injury:a prospective multicentric randomized study. Design presented for the Stoutenbeek Award of the 18th Annual Congress of ESICM Society, Berlin, 2004.
46. Bellomo R, Ronco C, Kellum J, Mehta R, Pa-levsky P, ADQI Work Group:Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs. Second International Consensus Conference of the Acute Dialysis Qua lit y I n it iat ive (A DQI) Group. Cr it ic a l Care 2004; 8:204-212.
47. Joannes-Boyau O, Honoré PM, Boer W, et al:The IVOIRE Study:description of the methodology and the design used. Electronic Supplemental Material. NCT00241228.
48. Jiang HL, Xhue WJ, Li DK, et al:Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gas-troenterol 2005; 11:4815-4821.
49. Laurent I, Adrie C, Vinsonneau C, et al:High-volume hemofiltration after out-of-hospital cardiac arrest:a randomized study. J Am Coll Cardiol 2005; 46:432-437.
50. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF:Outcome of critically ill patients treated with intermittent high-volume haemofiltration:a prospective cohort analysis. Intensive Care Med 1999; 25:814-821.
51. Piccinni P, Dan M, Barbacini S, et al:Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006; 32:80-86.
52. Honoré PM, Joannes-Boyau O, Merson L, Fleureau C, Roze H, Janvier G:Pulse high volume hemofiltration in septic shock plus acute renal failure (PULSHAR study). Blood Purif 2006; 24:267-268 (Abstr ac t).
53. Cornejo R, Downey P, Castro R, et al:High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006; 32:713-722.
54. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Ja nv ier G:Impac t of h igh volu me hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004; 50:102-109.
55. Metnitz PG, Krenn CG, Steltzer H, et al:Effects of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-2058.
56. Mehta RL, McDonald B, Gabbai FB, et al:Collaborative Group for treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute rena l failure. Kidney Int 2001; 60:1154-1163.
57. Hotchkiss RS, Karl IE:The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
58. Ronco C, Bellomo R:Acute renal failure and multiple organ dysfunction in the ICU:from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002; 25:733-747.
59. Seely AJ, Christou NV:Multiple organ dysfunction syndrome:exploring the paradigm of complex nonlinear systems. Crit Care Med 2000; 28:2193-2200.
60. Mayer J, Rau B, Gansauge F, Beger HG:Inflammatory mediators in human acute pancreatitis:clinical and pathopysiological implications. Gut 2000; 47:542-552.
61. Ertel W, Kremer JP, Kenney J, et al:Down regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85:1341-1347.
62. Grootendorst AF, van Bommel EF, van der Hoeven B, van Leengoed LA, van Osta AL:High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992; 18:235-240.
63. Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB:High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994; 2:72-78.
64. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL:Continuous veno-venous hemo-filtration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999; 27:1848-1855.
65. Journois D, Israel-Biet D, Pouard P, et al:High volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anes-thesiology 1996; 85:965-976.
66. Honoré PM, Jamez J, Wauthier M, et al:Removal of mediators by hemofiltration in septic shock:where do we stand? Ré anim Ur-gences 2000; 9:289-297.
67. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P:High-volume haemo-filtration in human septic shock. Intensive Ca re Med 2001; 27:978-986.
68. Ratanarat R, Brendolan A, Piccinni P, et al:Pulse-high volume haemofiltration for treatment of severe sepsis:effects on hemodynamics and surv ival. Crit Care 2005; 9:294-302.
69. Wang H, Zhang ZH, Yan XW, et al:Amelioration of haemodynamics an oxygen metabolism by continuous veno-venous hemofiltration in experimental pancreatitis. World J Gastroenterol 2005; 11:127-131.
70. Wa ng H, Li WQ, Zhou W, Li N, Li JS:Clinica l effects of continuous high volume hemofil-tration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 2003; 9:2096-2099.
71. Palevsky PM, Zhang JH, O'Connor TZ, et al:Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:7-20.
72. Ronco C, Honoré PM:Renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:1959-1962.
73. Ronco C, Cruz D, Oudemans-van-Straaten HM, Honoré PM, House A, Bin D, Gibney N:Dialysis dose in acute kidney injury:no time for therapeutic nihilism -a critical appraisal of the Acute Renal Failure Trial Network study. E-pub ahead of print.
74. Li CM, Chen JH, Zhang P, et al:Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 2007; 35:911-919.
75. Rimmelé T, Assadi A, Cattenoz M, et al:High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. E-pub ahead of print.
76. Joannes-Boyau O, Honoré PM, Boer W, Col-lin V:Are the synergistic effects of high volume haemofiltration and enhanced adsorption the missing key in sepsis modulation? E-pub ahead of print.
77. Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E:Factors influencing permanent catheter performance. J Vasc Access 2001; 2:106-109.
78. Ricci Z, Ronco C:Pre-versus post-dilution CVVH. Blood Purif 2005; 23:338-342.
79. Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB:Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation:a prospective study. Blood Purif 2007; 25:316-323.
80. Ratanarat R, Cazzavillan S, Ricci Z, et al:Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy. Blood Purif 2007; 25:106-111.
81. Arzuaga A, Isla A, Gascon AR, Maynar J, Corral E, Pedraz JL:Elimination of piper-acillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemo-filters:evaluation of the sieving coefficient. Blood Purif 2006; 24:347-354.
82. Kooman JP, van der Sande FM, Beerenhout CM, Leunissen KM:On-line filtration therapies:emerging horizons. Blood Purif 2006; 24:159-162.
83. Bellomo R, Kellum JA, Mehta R, Ronco C:The Acute Dialysis Quality Initiative II:the Vicenza conference. Adv Ren Replace Ther 2002; 9:290-293.
84. Tetta C, Bellomo R, Kellum J, et al:High volume hemofiltration in critically ill patients:why, when and how? Contrib Nephrol. Basel, Karger, 2004, vol 144, pp 362-375.
85. Joannes-Boyau O, Honoré PM:Haemo-filtration Study:clinicaltrials. gov ID NCT00241228 (last accessed in September 2008).
86. Honoré PM, Joannes-Boyau O, Gressens B:Blood and plasma treatments:High-volume hemofiltration:a global view. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 371-386.